Guangdong True Health Medical Technology Development Co., Ltd.

广东真健康医疗科技开发股份有限公司

02697.HK

Develops and commercializes percutaneous puncture and microwave ablation surgical robots for minimally invasive oncology care in China, with NMPA Class III registered puncture robots and ablation systems; ranked first in China's percutaneous puncture surgical robot market in 2025 with 28.0% revenue share, per CIC.

Filings

The documents are on HKEXnews; we link to the originals.

Matters the filing discloses

From the company’s latest filing; open a kind of matter to see how other companies disclosed it.

• Customer concentration
• Distribution model
• Outsourced production (OEM / contract manufacturing)
• Backlog and project economics
• Capacity and utilisation
• Losses and path to profitability
• Cash burn and runway
• Inventory level and ageing
• Investments and fair-value assets
• Adverse change after the track record
• Non-recurring gains and losses
• Related-party transactions and balances
• Chapter 18A biotech